CD34 and skin neoplasm: The capability of As3+ in inducing CSCs was first implicated in studies using in utero As3+ exposure in mice by Waalkes and colleagues [29, 30], which showed that fetal exposure to As3+ enhanced the susceptibility and aggressiveness of skin tumors with an increased number of CD34+ cells, the tentative CSCs.